PAMU
PTLA
Pictet Asset Management (UK)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-306,764
| Closed | -$2.19M | – | 1219 |
|
|
2020
Q1 | $2.19M | Sell |
306,764
-557,692
| -65% | -$3.98M | ﹤0.01% | 832 |
|
|
2019
Q4 | $20.6M | Buy |
864,456
+737,656
| +582% | +$17.6M | 0.04% | 425 |
|
|
2019
Q3 | $3.4M | Buy |
+126,800
| New | +$3.4M | 0.01% | 768 |
|
|
2019
Q2 | – | Sell |
-97,642
| Closed | -$3.39M | – | 1036 |
|
|
2019
Q1 | $3.39M | Buy |
97,642
+31,100
| +47% | +$1.08M | 0.01% | 760 |
|
|
2018
Q4 | $1.3K | Sell |
66,542
-197,030
| -75% | -$3.85K | ﹤0.01% | 861 |
|
|
2018
Q3 | $7.02M | Sell |
263,572
-318,854
| -55% | -$8.49M | 0.01% | 631 |
|
|
2018
Q2 | $22M | Sell |
582,426
-16,105
| -3% | -$608K | 0.05% | 374 |
|
|
2018
Q1 | $19.5M | Sell |
598,531
-112,203
| -16% | -$3.66M | 0.05% | 385 |
|
|
2017
Q4 | $34.6M | Buy |
710,734
+232,044
| +48% | +$11.3M | 0.09% | 278 |
|
|
2017
Q3 | $25.9M | Sell |
478,690
-43,547
| -8% | -$2.35M | 0.07% | 320 |
|
|
2017
Q2 | $19.2M | Sell |
522,237
-108,621
| -17% | -$4M | 0.06% | 355 |
|
|
2017
Q1 | $24.7M | Sell |
630,858
-43,894
| -7% | -$1.72M | 0.08% | 314 |
|
|
2016
Q4 | $15.1M | Buy |
674,752
+88,597
| +15% | +$1.99M | 0.06% | 369 |
|
|
2016
Q3 | $13.3M | Sell |
586,155
-97,486
| -14% | -$2.21M | 0.05% | 386 |
|
|
2016
Q2 | $18.8M | Buy |
683,641
+607,141
| +794% | +$16.7M | 0.07% | 310 |
|
|
2016
Q1 | $2.16M | Buy |
76,500
+62,000
| +428% | +$1.75M | 0.01% | 686 |
|
|
2015
Q4 | $746K | Sell |
14,500
-96,650
| -87% | -$4.97M | ﹤0.01% | 798 |
|
|
2015
Q3 | $4.74M | Sell |
111,150
-32,600
| -23% | -$1.39M | 0.02% | 565 |
|
|
2015
Q2 | $7.11M | Buy |
143,750
+43,500
| +43% | +$2.15M | 0.03% | 497 |
|
|
2015
Q1 | $3.58M | Sell |
100,250
-62,772
| -39% | -$2.24M | 0.01% | 653 |
|
|
2014
Q4 | $4.62M | Buy |
163,022
+75,272
| +86% | +$2.13M | 0.02% | 593 |
|
|
2014
Q3 | $2.22M | Buy |
87,750
+2,900
| +3% | +$73.3K | 0.01% | 717 |
|
|
2014
Q2 | $2.48M | Buy |
84,850
+22,100
| +35% | +$645K | 0.01% | 705 |
|
|
2014
Q1 | $1.63M | Buy |
62,750
+10,700
| +21% | +$277K | 0.01% | 755 |
|
|
2013
Q4 | $1.34M | Buy |
52,050
+5,300
| +11% | +$136K | 0.01% | 769 |
|
|
2013
Q3 | $1.25M | Buy |
46,750
+13,050
| +39% | +$349K | 0.01% | 765 |
|
|
2013
Q2 | $828K | Buy |
+33,700
| New | +$828K | ﹤0.01% | 781 |
|